Pfizer's Paxlovid Pill Gets Emergency Use Authorisation By US FDA For Oral Antiviral Treatment Of COVID-19
Pfizer’s Paxlovid pill on Wednesday got Emergency Use Authorisation by the US FDA for home treatment against COVID-19.
The Food and Drug Administration of the United States on Wednesday authorised Pfizer’s Paxlovid pill for home treatment against COVID-19. Paxlovid is the first pill against COVID-19 to get Emergency Use Authorisation (EUA) for oral antiviral treatment against the deadly virus. Notably, the drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.
Tweet By Pfizer:
BREAKING: @US_FDA granted Emergency Use Authorization (EUA) for our novel #COVID19 oral #antiviral treatment for high-risk patients aged 12+ weighing at least 40 kg (88 lbs), marking another historic milestone in the fight against COVID-19. #ScienceWillWin https://t.co/IRocj16hV9 pic.twitter.com/6gTqzfKNhp
— Pfizer Inc. (@pfizer) December 22, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Dec 23, 2021 10:12 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
